UK To Diverge On Biosimilar Data Requirements

But EU Off-Patent Industry Prefers Global Approach

The UK regulator wants to be a “catalyst for change” in reducing regulatory burdens, saying that better regulation based on science is in everyone’s interest.

GUIDANCE CONCEPT
The MHRA is to issue new guidance on biosimilars • Source: Shutterstock

More from United Kingdom

More from Europe